Breaking: Black woman developed alternative to breast cancer treatment

(Photo credit: Nigerian tribune)

By T. Carter Williamson,

Breast cancer is something far too many families have a personal connection with. Many women know either a mother, aunt, sister, cousin or friend who has suffered from this disease. Many of whom have suffered even during the therapy. But a young Black woman, Sandra Musujusu, has developed an alternative treatment for a subtype of breast cancer commonly found in black women.

According to the Nigerian Tribune, “My research is actually centered on the development of biodegradable polymers for treatment of breast cancer,” Musujusu told the Tribune. “I will be focusing on triple negative breast cancer, which is actually the aggressive subtype of breast cancer that is common with women from African ancestry.”

On July 6th, Mususjusu shared her alternative treatment for breast cancer with Dr. Jaime Saavedra Chanduvi, World Bank Director and his team when they visited the University, according to reports.

Musujusu’s treatment uses macro molecular science and seeks to develop bio-degradable polymer material which could be used as a method of treatment for breast cancer in the future.

Breast cancer is the most commonly diagnosed cancer among women around the world. In 2012, there were 1.7 million new cases worldwide, according to World Cancer Research Fund International. In the United States alone, black women with breast cancer have the highest mortality rate than any other race, according to the Susan G. Komen Foundation. It’s also the second leading cause of cancer death among black women.


Looking to Advertise? Contact the Crusader for more information.


  1. I am being treated for Stage 2A breast cancer right now — one more chemo treatment to go! My doctors have told me “we’re going for a cure here”, and I totally believe it WITHOUT QUESTION.
    Breast cancer is not automatically a death…

  2. Hi there, thank you for the great information. I did
    have a question though I think you might be able to help me with.
    I was wondering, Is treatment of multiple system atrophy (MSA) using intravenous immunoglobulin still in the trial stages?

    Or is it a regular treatment for MSA? If you could provide a little insight I would greatly appreciate it!


Please enter your comment!
Please enter your name here